CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-01 | Bosley Katrine President and CEO | Sale | −1,733 | $34.61 | $60K | 1,334,365 |
| 2018-03-01 | Bosley Katrine President and CEO | Sale | −4,800 | $35.87 | $172K | 1,329,565 |
| 2018-03-01 | Bosley Katrine President and CEO | Sale | −1,800 | $36.41 | $66K | 1,327,765 |
| 2018-02-16 | Hack Andrew A. F. Chief Financial Officer | Option exercise | +6,000 | $6.48 | $39K | 6,000 |
| 2018-02-16 | Hack Andrew A. F. Chief Financial Officer | Sale | −6,000 | $35.32 | $212K | 0 |
| 2018-02-16 | Hack Andrew A. F. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −6,000 | 63,662 | ||
| 2018-02-15 | Hack Andrew A. F. Chief Financial Officer | Option exercise | +6,000 | $6.48 | $39K | 6,000 |
| 2018-02-15 | Hack Andrew A. F. Chief Financial Officer | Sale | −6,000 | $34.61 | $208K | 0 |
| 2018-02-15 | Hack Andrew A. F. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −6,000 | 69,662 | ||
| 2018-02-14 | Hopfield Jessica Director | Grant or award · Stock Option (right to buy) | +23,076 | 23,076 | ||
| 2018-02-14 | Hack Andrew A. F. Chief Financial Officer | Option exercise | +6,000 | $6.48 | $39K | 6,000 |
| 2018-02-14 | Hack Andrew A. F. Chief Financial Officer | Sale | −6,000 | $32.71 | $196K | 0 |
| 2018-02-14 | Hack Andrew A. F. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −6,000 | 75,662 | ||
| 2018-02-07 | Bosley Katrine President and CEO | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2018-02-07 | Cox Gerald Frank Chief Medical Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2018-02-07 | Albright Charles Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +71,500 | 71,500 | ||
| 2018-02-07 | Hack Andrew A. F. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2018-02-01 | Bosley Katrine President and CEO | Sale | −5,533 | $35.79 | $198K | 1,338,898 |
| 2018-02-01 | Bosley Katrine President and CEO | Sale | −2,100 | $36.71 | $77K | 1,336,798 |
| 2018-02-01 | Bosley Katrine President and CEO | Sale | −700 | $37.60 | $26K | 1,336,098 |
Page 21 of 30 · 588 trades